Oral administration of L-carnitine at a dose of 1 g daily increases plasma concentrations of this substance to physiological levels in patients with end-stage renal disease who are undergoing hemodialysis
We wanted to make sure employers have the choice. Also on Thursday, the executive director of the Group Insurance Commission, the Massachusetts agency that provides health insurance for 460,000 state employees, said its been running a $20 million monthly deficit, partly due to rising claims from members taking GLP-1s to treat obesity
Reduced inflammation: Inflammatory markers often decrease, potentially reducing vascular inflammation that contributes to atherosclerosis
Rosenstock, J., et al., Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial